U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubChem Compound

Items: 1 to 20 of 900

1.
Safety and Effectiveness of High‐Intensity Statins Versus Low/Moderate‐Intensity Statins Plus Ezetimibe in Patients With Atherosclerotic Cardiovascular Disease for Reaching LDL‐C Goals: A Systematic Review and Meta‐Analysis
Hamidreza Soleimani, Asma Mousavi, Shayan Shojaei, Kiarash Tavakoli, Dorsa Salabat, Farid Farahani Rad, Mani K. Askari, John Nelson, Mohammed Ruzieh, Kaveh Hosseini
Clin Cardiol. 2024 Aug; 47(8): e24334. Published online 2024 Aug 12. doi: 10.1002/clc.24334
PMCID:
PMC11319735
AbstractArticlePDF–2.9M
2.
Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants
Jin-Woo Park, Hyewon Chung, Jong-Min Kim, Na Young Kim, Sung Hee Hong, Kyoung-Ah Kim, Ji-Young Park
Drugs R D. 2024 Jun; 24(2): 179–186. Published online 2024 May 22. doi: 10.1007/s40268-024-00460-y
PMCID:
PMC11315872
AbstractArticlePDF–818K
3.
Identification of ezetimibe and pranlukast as pharmacological chaperones for treatment of the rare disease Mucopolysaccharidosis type IVA
Carlos J. Alméciga-Diaz, Oscar A. Hidalgo, Sergio Olarte-Avellaneda, Alexander Rodríguez-López, Esteban Guzman, Rafael Garzón, Luisa Natalia Pimentel-Vera, María Alejandra Puentes-Tellez, Andrés Felipe Rojas-Rodriguez, Kirill Gorshkov, Rong Li, Wei Zheng
J Med Chem. Author manuscript; available in PMC 2024 Aug 1.
Published in final edited form as: J Med Chem. 2019 Jul 11; 62(13): 6175–6189. Published online 2019 Jun 25. doi: 10.1021/acs.jmedchem.9b00428
PMCID:
PMC11292729
AbstractArticlePDF–3.3M
4.
Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy
Leopoldo Perez de Isla, Evangelos Liberopoulos, Melania Dovizio, Chiara Veronesi, Luca Degli Esposti, Alberto Zambon
Adv Ther. 2024; 41(8): 3407–3418. Published online 2024 Jul 4. doi: 10.1007/s12325-024-02916-8
PMCID:
PMC11263226
AbstractArticlePDF–867K
5.
Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects
Hyunwook Ryu, Hyun Chul Kim, Inseung Jeon, In-Jin Jang, Joo-Youn Cho, Kyung Tae Kim, Jaeseong Oh
Drug Des Devel Ther. 2024; 18: 2641–2652. Published online 2024 Jul 1. doi: 10.2147/DDDT.S465652
PMCID:
PMC11225994
AbstractArticlePDF–6.9M
6.
The Effect of Different Statin‐Based Lipid‐Lowering Strategies on C‐Reactive Protein Levels in Patients With Stable Coronary Artery Disease
Zhimin Xue, Miao Ye, Hangpan Jiang, Duanbin Li, Xulin Hong, Zhezhe Chen, Ya Li, Binquan Zhou, Wenbin Zhang, Miaoyun Wang
Clin Cardiol. 2024 Jun; 47(6): e24301. Published online 2024 Jun 19. doi: 10.1002/clc.24301
PMCID:
PMC11187842
AbstractArticlePDF–312K
7.
Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III
Meshal Alanezi, Andrew T. Yan, Mary K. Tan, Ronald Bourgeois, Peiman Malek-Marzban, Rani Beharry, Suhaib Alkurtass, Gabor T. Gyenes, Pierre-Louis Nadeau, Nduka Nwadiaro, Sean Jedrzkiewicz, Dongsheng Gao, Harish Chandna, William B. Nelson, Shaun G. Goodman, for the North American ACS Reflective III Pilot Investigators
Cardiology. 2024 Jun; 149(3): 266–274. Published online 2024 Jan 30. doi: 10.1159/000536392
PMCID:
PMC11151984
AbstractArticle
8.
Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM?
Il Rae Park, Jun Sung Moon
Diabetes Metab J. 2024 May; 48(3): 387–389. Published online 2024 May 22. doi: 10.4093/dmj.2024.0168
PMCID:
PMC11140406
ArticlePDF–103K
9.
Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings
Paul Muntner, Lama Ghazi, Jenna Jones, Nafeesa Dhalwani, Bharat Poudel, Ying Wen, Ligong Chen, Zhixin Wang, Vera Bittner, Bethany Kalich, Michael E. Farkouh, Mark Woodward, Lisandro D. Colantonio, Robert S. Rosenson
Adv Ther. 2024; 41(6): 2399–2413. Published online 2024 Apr 30. doi: 10.1007/s12325-024-02868-z
PMCID:
PMC11133193
AbstractArticlePDF–531K
10.
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany
Wolfgang Koenig, Elke S. Lorenz, Lea Beier, Ioanna Gouni-Berthold
Clin Res Cardiol. 2024; 113(6): 812–821. Published online 2023 Aug 21. doi: 10.1007/s00392-023-02257-6
PMCID:
PMC11108924
AbstractArticlePDF–1018K
11.
Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study
Lusheng Miao, Taosheng Miao, Ying Zhang, Jin Hao
BMC Cancer. 2024; 24: 602. Published online 2024 May 17. doi: 10.1186/s12885-024-12366-8
PMCID:
PMC11102253
AbstractArticlePDF–1.9M
12.
Repositioning of ezetimibe for the treatment of idiopathic pulmonary fibrosis
Chanho Lee, Se Hyun Kwak, Jisu Han, Ju Hye Shin, Byunghun Yoo, Yu Seol Lee, Jeong Su Park, Beom Jin Lim, Jin Gu Lee, Young Sam Kim, Song Yee Kim, Soo Han Bae
Eur Respir J. 2024 May; 63(5): 2300580. Published online 2024 May 16. doi: 10.1183/13993003.00580-2023
PMCID:
PMC11096666
AbstractArticlePDF–1.7M
13.
Atingimento das Metas de Colesterol LDL em Pacientes com Histórico de Infarto Agudo do Miocárdio: Estudo Transversal do Mundo Real
Daniel A. Gomes, Mariana Sousa Paiva, Pedro Freitas, Francisco Albuquerque, Maria Rita Lima, Rita Reis Santos, João Presume, Marisa Trabulo, Carlos Aguiar, Jorge Ferreira, António M. Ferreira, Miguel Mendes
Arq Bras Cardiol. 2024 Jan; 121(1): e20230242. Portuguese. Published online 2024 Feb 22. doi: 10.36660/abc.20230242
PMCID:
PMC11081093
AbstractArticlePDF–587K
14.
Ezetimibe inhibits the migration and invasion of triple‐negative breast cancer cells by targeting TGFβ2 and EMT
Lingkai Kong, Qinyu He, Ding Ma, Weiwei Shi, Qilei Xin, Chunping Jiang, Junhua Wu
FEBS Open Bio. 2024 May; 14(5): 831–842. Published online 2024 Mar 26. doi: 10.1002/2211-5463.13797
PMCID:
PMC11073500
AbstractArticlePDF–1.4M
15.
Treatment of Ezetimibe lowers total and low-density lipoprotein cholesterol in hypercholesterolemic dogs with hyperadorenocorticism
Hitomi ODA, Aiko HAGA, Kaoru KOYAMA, Kureha GOKITA, Ran AKIYAMA, Takumi KOMIYA, Shinogu HASEGAWA, Toshinori SAKO, Akihiro MORI
J Vet Med Sci. 2024 Apr; 86(4): 363–367. Published online 2024 Feb 22. doi: 10.1292/jvms.23-0461
PMCID:
PMC11061567
AbstractArticlePDF–1.2M
16.
Higher Cholesterol Absorption Marker at Baseline Predicts Fewer Cardiovascular Events in Elderly Patients Receiving Hypercholesterolemia Treatment: The KEEP Study
Masanari Kuwabara, Jun Sasaki, Yasuyoshi Ouchi, Shinichi Oikawa, Kiyotaka Nakagawa, Masao Sato, Shinji Koba, Suminori Kono, Tetsunori Saikawa, Hidenori Arai
J Am Heart Assoc. 2024 Feb 6; 13(3): e031865. Published online 2024 Jan 19. doi: 10.1161/JAHA.123.031865
PMCID:
PMC11056156
AbstractArticlePDF–836K
17.
Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies
Frederick J. Raal, Robert A. Hegele, Andrea Ruzza, J. Antonio G. López, Ajay K. Bhatia, Johnny Wu, Huei Wang, Daniel Gaudet, Albert Wiegman, Jian Wang, Raul D. Santos
Arterioscler Thromb Vasc Biol. 2024 May; 44(5): 1156–1164. Published online 2024 Mar 28. doi: 10.1161/ATVBAHA.123.320268
PMCID:
PMC11042515
AbstractArticlePDF–784K
18.
Treatment of dyslipidemia in acute coronary syndrome
Satyavir Yadav, Jitendra Pal Singh Sawhney
Indian Heart J. 2024 Mar; 76(Suppl 1): S51–S57. Published online 2024 Feb 1. doi: 10.1016/j.ihj.2024.01.011
PMCID:
PMC11019335
AbstractArticlePDF–657K
19.
Managing dyslipidaemia in patients with chronic kidney disease
Ashwani Mehta
Indian Heart J. 2024 Mar; 76(Suppl 1): S90–S92. Published online 2024 Jan 24. doi: 10.1016/j.ihj.2024.01.012
PMCID:
PMC11019316
AbstractArticlePDF–312K
20.
Lipid‐Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Sylvain Bétrisey, Moa Lina Haller, Orestis Efthimiou, Alexandre Speierer, Cinzia Del Giovane, Elisavet Moutzouri, Manuel R. Blum, Drahomir Aujesky, Nicolas Rodondi, Baris Gencer
J Am Heart Assoc. 2024 Feb 20; 13(4): e030714. Published online 2024 Feb 7. doi: 10.1161/JAHA.123.030714
PMCID:
PMC11010101
AbstractArticlePDF–1.6M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center